![](/img/cover-not-exists.png)
183TiPNeoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial
Ignatiadis, M, Brandao, M, Maetens, M, Ponde, N, Martel, S, Drisis, S, Veys, I, Mazy, S, Bollue, E, Neven, P, Duhoux, F P, Chapiro, J, Awada, A H, Besse-Hammer, T, Paesmans, M, Piccart, M, Vuylsteke,Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy269.181
Date:
October, 2018
File:
PDF, 79 KB
english, 2018